Send a Tweet
Most Popular Choices
Poll Analyses
Share on Facebook 28 Share on Twitter Printer Friendly Page More Sharing
Sci Tech   

Scientists accidentally discover new type of immune cell that kills most cancers

Author 7804
Follow Me on Twitter     Message molly cruz
Become a Fan
  (15 fans)

Until now, no one believed this kind of broad-spectrum cure for cancer was possible.

The researchers were toying around with a special type of genetic screening using CRISPR-Cas9, a technology derived from the genomes of bacteria that is capable of flagging and editing genes within organisms. They found a special type of human immune cell, or T-cell, that's capable of targeting cancerous tissue and killing it while leaving normal tissue untouched.

Read the rest of the story HERE:

At www.mnn.com

 

Must Read 1   Interesting 1   Inspiring 1  
Rate It | View Ratings

molly cruz Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Born in Long Island public school year in Sweden as exchange student, went to Harvard one year, Cooper Union in NYC as Art student. Have two children, one of whom is rock mogul, the other has three daughters, one of whom has two daughters, making me (more...)
 
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation: